Nidan Laboratories and Healthcare (NSE:NIDAN) Operating Margin %: 9.94% (As of Mar. 2025)


NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.60
Valuation Possible Value Trap
View Full Analysis

What is Nidan Laboratories and Healthcare Operating Margin %?

Nidan Laboratories and Healthcare NSE:NIDAN 67 Operating Margin % is 9.94% as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100 (Possible Value Trap). Among 203 Medical Diagnostics & Research companies, Nidan Laboratories and Healthcare ranks better than 69.95% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Nidan Laboratories and Healthcare's Operating Income for the six months ended in Mar. 2025 was ₹13.9 Mil. Nidan Laboratories and Healthcare's Revenue for the six months ended in Mar. 2025 was ₹139.9 Mil. Therefore, Nidan Laboratories and Healthcare's Operating Margin % for the quarter that ended in Mar. 2025 was 9.94%.

The historical rank and industry rank for Nidan Laboratories and Healthcare's Operating Margin % or its related term are showing as below:


NSE:NIDAN's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -3.29
* Ranked among companies with meaningful Operating Margin % only.

Nidan Laboratories and Healthcare's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Nidan Laboratories and Healthcare's Operating Income for the six months ended in Mar. 2025 was ₹13.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ₹26.5 Mil.


Nidan Laboratories and Healthcare  (NSE:NIDAN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Nidan Laboratories and Healthcare Operating Margin % Related Terms


Nidan Laboratories and Healthcare Operating Margin % Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Operating Margin % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Operating Margin %
Get a 7-Day Free Trial 27.99 25.37 15.92 16.23 10.82

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1.33 17.39 15.13 11.98 9.94

NSE:NIDAN vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nidan Laboratories and Healthcare Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's Operating Margin % falls into.


NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Nidan Laboratories and Healthcare's Operating Margin % for the fiscal year that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (A: Mar. 2025 ) / Revenue (A: Mar. 2025 )
=26.534 / 245.275
=10.82 %

Nidan Laboratories and Healthcare's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=13.912 / 139.948
=9.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 9.94% mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Operating Margin % of 9.94% as of Mar. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Nidan Laboratories and Healthcare and its competitors. According to the industry distribution chart, Nidan Laboratories and Healthcare ranks #61 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 30%.
Is Nidan Laboratories and Healthcare's Operating Margin % too high?
Nidan Laboratories and Healthcare's current Operating Margin % is 9.94%. Based on the distribution chart, Nidan Laboratories and Healthcare ranks #61 out of 203 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Nidan Laboratories and Healthcare ranks #61 out of 203 companies for Operating Margin %. This puts Nidan Laboratories and Healthcare in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Operating Margin % is 9.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Nidan Laboratories and Healthcare (NSE:NIDAN) is currently considered Possible Value Trap. The current Operating Margin % is 9.94%. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Operating Margin % is 9.94% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.60
Price